PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS
NCT ID: NCT05444764
Last Updated: 2024-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
800 participants
OBSERVATIONAL
2021-09-16
2024-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Noninvasive Ventilation After Extubation in Hypercapnic Patients
NCT01047852
Extubation of Patients on ECLS is Associated With a Reduction in Complications Related to Mechanical Ventilation: Retrospective Single-centre Study
NCT03295357
Non-Invasive Ventilation After Extubation in Hypercapnic Patients
NCT00539708
Criteria of Extubation Failure of Brain Injured Patients. Elaboration of a Prognostic Score.
NCT02235376
Evaluation of Risk Factors Regarding Extubation Failure in Severe Brain Injured Patients.
NCT02426242
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Develop a (dynamic) prediction tool for survival and quality of life outcomes 1 year after ECLS support for the situation at baseline and 7 days after ECLS initiation
2. Study the association between application of left ventricular unloading and ECLS support duration and weanability
3. Description of the incidence of VA ECLS weaning failure and identification of predictors for VA ECLS weaning failure
Under this umbrella research protocol, the data collected by this observational multicenter study can also be reused for potential novel substudies with the objective to improve the quality of care and the efficiency of current treatment strategies involving ECLS.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All ECLS indications (refractory cardiac, circulatory and/or respiratory failure)
* Surgical and medical patients
Exclusion Criteria
* ECLS confined to cardiac surgery in the operating room (OR) or in the catheterization laboratory
* Objection against use of clinical data (opt-out principle)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Leiden University Medical Center
OTHER
Erasmus Medical Center
OTHER
St. Antonius Hospital
OTHER
Catharina Ziekenhuis Eindhoven
OTHER
Isala
OTHER
UMC Utrecht
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Dirk W. Donker
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dirk W Donker, Professor
Role: PRINCIPAL_INVESTIGATOR
UMC Utrecht
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catharinaziekenhuis Eindhoven
Eindhoven, North Brabant, Netherlands
Isala Hospital
Zwolle, Overijssel, Netherlands
Leids Universitair Medisch Centrum
Leiden, South Holland, Netherlands
Erasmus Medisch Centrum
Rotterdam, South Holland, Netherlands
Antoniusziekenhuis Nieuwegein
Nieuwegein, Utrecht, Netherlands
UMC Utrecht
Utrecht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-604
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.